Several studies demonstrated an “IFN signature” in the early stages and event before the development of childhood onset SLE, Sjogren’s syndrome, inflammatory myositis, type 1 diabetes mellitus, autoimmune pancreatitis and thyroiditis and in IgG4- related disorders [250,251,252,253,254]. This evidence concerns the gene IFNA1 and diabetes mellitus.